Biomedical Engineering Reference
In-Depth Information
255. Alizadeh, D., Zhang, L., Hwang, J., Schluep, T., Badie, B., 2010, “ Tumor-
associated macrophages are predominant carriers of cyclodextrin-based
nanoparticles into gliomas,” Manomedicine, 6, pp. 382-390.
256. Tian, X., Lin, X., Wei, F., Feng, W., Huang, Z., et al., 2011, “Enhanced brain
targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate
nanoparticles,” Int. J. Nanomed., 6, pp. 445-452.
257. Steiniger, S.C.J., Kreuter, J., Khalansky, A.S., Skidan, I.N., Bobruskin, A.I.,
et al., 2004, “Chemotherapy of glioblastoma in rats using doxorubicin-loaded
nanoparticles,” Int. J. Cancer, 109, pp. 759-767.
258. Orringer, D.A., Koo, Y., Kopelman, R., Sagher, O., 2009, “Small solutions for
big problems: the application of nanoparticles to brain tumor diagnosis and
therapy,” Clin. Pharmacol. Ther., 85, pp. 531-534.
259. Zara, G.P., Cavalli, R., Bargoni, A., Fundarò, A., Vighetto, D., 2002,
“Intravenous administration to rabbits of non-stealth and stealth doxorubicin-
loaded solid lipid nanoparticles at increasing concentrations of stealth agent:
pharmacokinetics and distribution of doxorubicin in brain and other tissues,”
J. Drug Target., 10, pp. 327-335.
260. Kuroda, J., Kuratsu, J., Yasunaga, M., 2009, “Potent antitumor effect of SN-
38-incorporating polymeric micelle, NK012, against malignant glioma,” Int. J.
Cancer, 124, pp. 2505-2511.
261. Ljubimova, J.Y., Fujita, M., Khazenzon, N.M., Lee, B.S., Wachsmann-Hogiu,
S., et al., 2008, “Nanoconjugate based on polymalic acid for tumor targeting,”
Chem. Biol. Interact., 171, pp. 195-203.
262. Chertok, B., David, A.E., Yang, V.C., 2010, “Polyethyleneimine-modified iron
oxide nanoparticles for brain tumor drug delivery using magnetic targeting and
intra-carotid administration,” Biomaterials, 31, pp. 6317-6324.
263. Etame, A.B., Diaz, R.J., O'Reilly, M.A., Smith, C.A., Mainprize, T.G., et al.,
2012, “Enhanced delivery of gold nanoparticles with therapeutical potential
into the brain using MRI-guided focused ultrasound,” Nanomedicine, (in
press).
264. Yukawa, H., Mizufune, S., Mamori, C., Kagami, Y., Oishi, K., et al., 2009,
“Quantum dots for labeling adipose tissue-derived stem cells,” Cell Transplant.,
18, pp. 591-599.
265. Yang, F., Cho, S.W., Son, S.M., Bogatyrev, S.R., Singh, D., et al., 2010,
“Genetic engineering of human stem cells for enhanced angiogenesis using
biodegradable polymeric nanoparticles,” Proc. Natl. Acad. Sci. U.S.A., 107,
pp. 3317-3322.
266. Caruso, G., Caffo, M., Raudino, G., Tomasello, C., Alafaci, C., Tomasello, F., 2012,
“Nanomedicine and Brain Tumors Treatment,” in Patenting Nanomedicines.
Legal Aspects, Intellectual Property and Grant Opportunities, E.B. Souto, ed.,
Springer Verlag, Berlin Heidelberg, pp. 167-204.
267. Shubayev, V.I., Pisanic II, T.R., Jin, S., 2009, “Magnetic nanoparticles for
theragnostics,” Adv. Drug Deliv. Rev., 61, pp. 467-477.
268. Wankhede, M., Bouras, A., Kaluzova, M., Hadjipanayis, C.G., 2012,
“Magnetic nanoparticles: an emerging technology for malignant brain tumor
imaging and therapy,” Exp. Rev. Clin. Pharmacol., 5, pp. 173-186.
